Scilex Holding Co (SCLX)
0.6781
-0.06
(-8.36%)
USD |
NASDAQ |
Nov 14, 16:00
0.67
-0.01
(-1.19%)
After-Hours: 20:00
Scilex Enterprise Value: 194.99M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 194.99M |
| November 12, 2024 | 198.84M |
| November 11, 2024 | 203.02M |
| November 08, 2024 | 213.47M |
| November 07, 2024 | 226.08M |
| November 06, 2024 | 238.46M |
| November 05, 2024 | 235.82M |
| November 04, 2024 | 224.60M |
| November 01, 2024 | 225.47M |
| October 31, 2024 | 224.01M |
| October 30, 2024 | 221.57M |
| October 29, 2024 | 228.58M |
| October 28, 2024 | 226.92M |
| October 25, 2024 | 210.98M |
| October 24, 2024 | 215.13M |
| October 23, 2024 | 217.88M |
| October 22, 2024 | 225.34M |
| October 21, 2024 | 226.60M |
| October 18, 2024 | 225.29M |
| October 17, 2024 | 222.20M |
| October 16, 2024 | 212.11M |
| October 15, 2024 | 203.95M |
| October 14, 2024 | 201.15M |
| October 11, 2024 | 201.56M |
| October 10, 2024 | 200.93M |
| Date | Value |
|---|---|
| October 09, 2024 | 205.26M |
| October 08, 2024 | 208.08M |
| October 07, 2024 | 218.15M |
| October 04, 2024 | 226.60M |
| October 03, 2024 | 210.14M |
| October 02, 2024 | 212.98M |
| October 01, 2024 | 214.62M |
| September 30, 2024 | 219.31M |
| September 27, 2024 | 221.41M |
| September 26, 2024 | 216.08M |
| September 25, 2024 | 202.89M |
| September 24, 2024 | 205.70M |
| September 23, 2024 | 201.10M |
| September 20, 2024 | 229.24M |
| September 19, 2024 | 233.19M |
| September 18, 2024 | 230.55M |
| September 17, 2024 | 234.51M |
| September 16, 2024 | 241.09M |
| September 13, 2024 | 249.00M |
| September 12, 2024 | 237.14M |
| September 11, 2024 | 241.09M |
| September 10, 2024 | 239.77M |
| September 09, 2024 | 231.87M |
| September 06, 2024 | 234.51M |
| September 05, 2024 | 243.73M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
131.66M
Minimum
Sep 29 2023
2.163B
Maximum
Apr 12 2023
551.69M
Average
305.65M
Median
Jul 23 2024
Enterprise Value Benchmarks
| Abbott Laboratories | 208.17B |
| Masimo Corp | 9.271B |
| Oramed Pharmaceuticals Inc | -58.86M |
| Perspective Therapeutics Inc | 378.39M |
| Electromed Inc | 224.00M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -37.58M |
| Revenue (Quarterly) | 16.37M |
| Total Expenses (Quarterly) | 31.99M |
| EPS Diluted (Quarterly) | -0.31 |
| Gross Profit Margin (Quarterly) | 73.18% |
| Profit Margin (Quarterly) | -229.6% |
| Earnings Yield | -210.9% |
| Normalized Earnings Yield | -206.44 |